Home
/
CROSS COUNTRY HEALTHCARE INC
/
Financials
/
Quarterly
CROSS COUNTRY HEALTHCARE INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CROSS COUNTRY HEALTHCARE INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2020
Sep 30, 2020
$193.97M
Nov 5, 2020
Q2
2020
Jun 30, 2020
$216.78M
Aug 6, 2020
Q1
2020
Mar 31, 2020
$210.06M
May 8, 2020
Q3
2020
Sep 30, 2019
$209.20M
Nov 5, 2020
Q2
2020
Jun 30, 2019
$202.76M
Aug 6, 2020
Q1
2020
Mar 31, 2019
$195.17M
May 8, 2020
Q3
2019
Sep 30, 2018
$200.72M
Nov 6, 2019
Q2
2019
Jun 30, 2018
$204.57M
Aug 1, 2019
Q1
2019
Mar 31, 2018
$210.29M
May 2, 2019
Q3
2018
Sep 30, 2017
$228.49M
Nov 2, 2018
Q2
2018
Jun 30, 2017
$209.31M
Aug 2, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$250.05M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$274.07M
Aug 6, 2025
Q1
2025
Mar 31, 2025
$293.41M
May 7, 2025
Q3
2025
Sep 30, 2024
$315.12M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$339.77M
Aug 6, 2025
Q1
2025
Mar 31, 2024
$379.17M
May 7, 2025
Q3
2024
Sep 30, 2023
$442.29M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$540.70M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$622.71M
May 2, 2024
Q3
2024
Dec 31, 2022
$2.80B
Nov 7, 2024
Q3
2023
Sep 30, 2022
$636.10M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$753.56M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$788.73M
May 4, 2023
Q3
2022
Sep 30, 2021
$374.91M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$331.83M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$329.24M
May 5, 2022
Q3
2021
Sep 30, 2020
$193.97M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$216.78M
Aug 5, 2021
Q1
2021
Mar 31, 2020
$210.06M
May 6, 2021
Q3
2020
Sep 30, 2019
$209.20M
Nov 5, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($4.77M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($6.66M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($490.0K)
May 7, 2025
Q3
2025
Sep 30, 2024
$2.56M
Nov 12, 2025
Q2
2025
Jun 30, 2024
($16.05M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
$2.69M
May 7, 2025
Q3
2024
Dec 31, 2023
$72.63M
Nov 7, 2024
Q3
2024
Sep 30, 2023
$12.81M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$21.35M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$29.44M
May 2, 2024
Q3
2024
Dec 31, 2022
$185.98M
Nov 7, 2024
Q3
2023
Sep 30, 2022
$34.79M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$52.89M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$61.98M
May 4, 2023
Q3
2022
Sep 30, 2021
$23.43M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$11.55M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$19.45M
May 5, 2022
Q3
2021
Sep 30, 2020
($1.33M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($14.15M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($2.09M)
May 6, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($5.97M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($5.86M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($977.0K)
May 7, 2025
Q3
2025
Sep 30, 2024
$2.85M
Nov 12, 2025
Q2
2025
Jun 30, 2024
($19.21M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
$2.92M
May 7, 2025
Q3
2024
Sep 30, 2023
$20.30M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$35.19M
Aug 1, 2024
Q1
2024
Mar 31, 2023
$43.80M
May 2, 2024
Q3
2024
Dec 31, 2022
$269.88M
Nov 7, 2024
Q3
2023
Sep 30, 2022
$52.18M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$78.84M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$90.63M
May 4, 2023
Q3
2022
Sep 30, 2021
$26.45M
Nov 3, 2022
Q2
2022
Jun 30, 2021
$15.90M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$20.99M
May 5, 2022
Q3
2021
Sep 30, 2020
($381.0K)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($13.69M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($754.0K)
May 6, 2021
Q3
2020
Sep 30, 2019
$119.0K
Nov 5, 2020